Morán-Torres Rafael, Castillo González David A, Durán-Pastén Maria Luisa, Aguilar-Maldonado Beatriz, Castro-Obregón Susana, Del Rio Gabriel
Department of Biochemistry and Structural Biology, Institute of Cellular Physiology, National Autonomous University of Mexico, UNAM, Mexico City 04510, Mexico.
Laboratorio Nacional de Canalopatias, National Autonomous University of Mexico, UNAM, Mexico City 04510, Mexico.
Pharmaceutics. 2021 Jul 22;13(8):1119. doi: 10.3390/pharmaceutics13081119.
Cell penetrating peptides (CPPs) are molecules capable of passing through biological membranes. This capacity has been used to deliver impermeable molecules into cells, such as drugs and DNA probes, among others. However, the internalization of these peptides lacks specificity: CPPs internalize indistinctly on different cell types. Two major approaches have been described to address this problem: (i) targeting, in which a receptor-recognizing sequence is added to a CPP, and (ii) activation, where a non-active form of the CPP is activated once it interacts with cell target components. These strategies result in multifunctional peptides (i.e., penetrate and target recognition) that increase the CPP's length, the cost of synthesis and the likelihood to be degraded or become antigenic. In this work we describe the use of machine-learning methods to design short selective CPP; the reduction in size is accomplished by embedding two or more activities within a single CPP domain, hence we referred to these as moonlighting CPPs. We provide experimental evidence that these designed moonlighting peptides penetrate selectively in targeted cells and discuss areas of opportunity to improve in the design of these peptides.
细胞穿透肽(CPPs)是能够穿过生物膜的分子。这种能力已被用于将诸如药物和DNA探针等不能渗透的分子递送至细胞中。然而,这些肽的内化缺乏特异性:CPPs在不同细胞类型上无差别地内化。已经描述了两种主要方法来解决这个问题:(i)靶向,即将受体识别序列添加到CPP中;(ii)激活,即一旦非活性形式的CPP与细胞靶标成分相互作用就被激活。这些策略产生了多功能肽(即穿透和靶标识别),这增加了CPP的长度、合成成本以及被降解或变得具有抗原性的可能性。在这项工作中,我们描述了使用机器学习方法来设计短的选择性CPP;通过将两种或更多种活性嵌入单个CPP结构域中来实现尺寸的减小,因此我们将这些称为兼职CPPs。我们提供了实验证据,证明这些设计的兼职肽在靶向细胞中选择性穿透,并讨论了在这些肽的设计中有待改进的机会领域。